DUBLIN, Nov. 2, 2022 /PRNewswire/ — The “Ophthalmology Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030” report has been added to ResearchAndMarkets.com’s offering.
In recent years, rapid development is observed in ophthalmology devices with continuous evolving technology in diagnostic and vision care. Ophthalmology Devices Market is Expected to Grow at 5% by 2030. With technological advancement, diagnosis and treatment of ophthalmic condition and disorders at early stage has become possible. Rising prevalence of diabetes and geriatric population play pivotal role in driving the ophthalmology devices market.
Perpetual rise in aged population is observed that would reach its peak in coming years. This age group is at high risk of contracting eye disease and thus need timely diagnosis and treatment at the earliest to avoid further complication. Improved diagnostic and visualization and rising awareness about clear vision for quality of life is propelling the demand for ophthalmology devices.
There is presence of novel products and diagnostic treatment methodologies in the market that are well adopted of the physician and patient population. Speedy growth of overall medical devices would further drive growth for the ophthalmology devices market in the forecast period. Improvement in healthcare infrastructure, ageing population and life style related disease would led the growth of ophthalmology devices market. Though challenges such as reimbursement policy might hinder the market growth.
Vision care occupies a large share of market revenue
Vision care occupies a large share of market revenue of the global ophthalmic device market as rise in the number of ophthalmic complications, technological advancement in the design and manufacture of vision care products, and rising demand for contact lenses for its aesthetic appearance. It comprises spectacles and contact lenses, in which market size of spectacle is the highest. North America occupies the largest regional market of ophthalmology devices due to high awareness about ophthalmic disorder and complication related, well-established healthcare infrastructure and large pool of geriatric population.
Asia-Pacific will show significant market growth during the forecast period
In the base 2020, North America was observed as the largest revenue contributing segment due to key driving factors such as high treatment awareness, adoption of advanced ophthalmology devices, most of the key players are based in this region, technological advancement, and easy product availability due to high penetration of distribution channel. It is anticipated that Asia-Pacific will show significant market growth during the forecast period due to developing economic conditions, rising investment in health care infrastructure, increasing focus of key manufacturers in emerging APAC countries, increasing consumer health and wellness awareness in the upper-middle-income segment, and populous countries in APAC.
Market Segmentation
Device Type
Diagnostic Devices
Optical Coherence Tomography Scanners
Ophthalmic Ultrasound Imaging Systems
Fundus Cameras
Ophthalmoscopes
Retinoscopes
Wavefront Aberrometers
Corneal Topography Systems
Autorefractors/Phoropters
Keratometers
Specular Microscopes
Perimeters/Visual Field Analyzers
Tonometers
Slit Lamps
Surgical Devices
Cataract Surgery Devices
Glaucoma Surgery Devices
Refractive Surgery Devices
Vitreoretinal Surgery Devices
Vision Care
Spectacles
Contact lenses
Key Questions Answered in this Report
What are the key micro and macro environmental factors that are impacting the growth of Ophthalmology Devices market?
What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
Estimated forecast and market projections up to 2030.
Which segment accounts for the fastest CAGR during the forecast period?
Which market segment holds a larger market share and why?
Are low and middle-income economies investing in the Ophthalmology Devices market?
Which is the largest regional market for Ophthalmology Devices market?
What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
Which are the key trends driving Ophthalmology Devices market growth?
Who are the key competitors and what are their key strategies to enhance their market presence in the Ophthalmology Devices market worldwide?
Key Topics Covered:
1. Preface
2. Executive Summary
3. Ophthalmology Devices Market: Business Outlook & Market Dynamics
4. Ophthalmology Devices Market: By Device Type, 2020-2030, USD (Million)
5. North America Ophthalmology Devices Market, 2020-2030, USD (Million)
6. UK and European Union Ophthalmology Devices Market, 2020-2030, USD (Million)
7. Asia Pacific Ophthalmology Devices Market, 2020-2030, USD (Million)
8. Latin America Ophthalmology Devices Market, 2020-2030, USD (Million)
9. Middle East and Africa Ophthalmology Devices Market, 2020-2030, USD (Million)
10. Company Profile
Companies Mentioned
Bausch & Lomb Inc.
Essilor International S.A.
Carl Zeiss Meditec AG
Alcon Inc.
CooperVision
SynergEyes Inc.
Topcon Corporation
Johnson & Johnson
Haag-Streit Group
Nidek Co. Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/wc4fxu
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/ophthalmology-devices-global-market-2022-rising-prevalence-of-diabetes-and-geriatric-population-boosting-growth-301665939.html
SOURCE Research and Markets
Wednesday could be the turning point.
The emblematic brand of 4×4 has just filed for bankruptcy in one of the most important automobile markets.
Yahoo Finance Live reacts to Tesla's recent announcements that the EV developer is pushing back its production schedule again for its long-awaited Cybertruck.
Investors have routinely sold Amazon stock this year, but there are several reasons to be optimistic about the company.
Millennials have given up on stocks. Act accordingly.
Paramount Global reported third quarter earnings before the bell on Wednesday as the industry grapples with unfavorable linear TV trends and a slowdown in advertising spend.
Pharmaceutical stocks were leading the gains on London’s benchmark index after GSK raised its outlook for the full year on the back of strong demand for its shingles vaccine.
The key for markets will be what signals Fed Chairman Jerome Powell sends about the prospects for future rate increases.
With the Federal Reserve holding its November FOMC meeting now, there’s plenty of speculation on the central bank’s next move. The conventional wisdom says the Fed will hike rates again, by another 75 basis points – the fourth such hike in a row this year. But after that, no one knows. Inflation remains above 8%, so the Fed’s tighter monetary policies have clearly not reined in high prices – yet. According to Fundstrat, however, the Fed has moved far enough in that direction, and we’ll start to
Since the three major U.S. indexes achieved their all-time highs between the midpoint of November 2021 and the first week of January, each has fallen into a bear market, with peak declines ranging from 22% to 38%. Of course, optimism can vary quite significantly on Wall Street. What follows are three high-octane growth stocks that select analysts and pundits believe offer upside ranging from 357% to as much as 571%!
When General Motors (NYSE: GM) reported its huge earnings beat last week — sales up 56% year over year, profits rising 39%, and a tremendous $4.6 billion in free cash flow (FCF) — it seemed to set the stage for a similarly good news day from Ford Motor Company (NYSE: F), which would report earnings one day later. Reporting earnings late on Wednesday, Ford's numbers weren't entirely horrible — they just weren't anywhere near as good as GM's. Sales of $39.4 billion rose 10% year over year, and Ford generated respectable free cash flow of $3.6 billion.
These fast-growing companies can be bought at attractive valuations if their share prices head lower.
Devon Energy (DVN) delivered earnings and revenue surprises of 2.35% and 10.58%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Bausch + Lomb Corporation, (NYSE/TSX: BLCO) ("Bausch + Lomb" or the "Company", "we" or "our"), a leading global eye health company dedicated to helping people see better to live better, today announced its third-quarter 2022 financial results.
Plug Power (PLUG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Americans are still quitting at near-record levels, according to new data from the Bureau of Labor Statistics. The overall quits rate—the percentage of the employed population that quit within a month—was 2.7% in September, the same as it was two months earlier. The quits rate for the private sector alone slowed down a hair, though, from 3% to 2.9%.
Healthcare benefits sales continued to power both the top and bottom line for CVS, which boosted its full-year profit forecast for the third consecutive quarter.
Year-to-date, Roku shares have experienced rough price action, down more than 70% and widely lagging the general market.
DraftKings' (DKNG) third-quarter 2022 performance is likely to have benefited from the robust demand for mobile sports betting and expansion efforts in new states.
In the latest trading session, NIO Inc. (NIO) closed at $9.71, marking a +0.41% move from the previous day.